Share this
Twitter
Myspace
Digg
Del.icio.us
Reddit
Slashdot
Furl
Yahoo
Technorati
Newsvine
Facebook
Export PDF
Print
E-mail
Tags
BY BOB HOLT
NEWJERSEYNEWSROOM.COM
Chemotherapy has long been considered an aggressive and painful form of cancer therapy. It was also considered necessary and the most effective treatment.
Now a recent study has shown that chemotherapy can possibly encourage tumor growth. Researchers were initially attempting to determine why cancer cells are easy to kill in a laboratory but so hard to stop in a human body.
The New York Daily News reported that they tested tissue collected from men with prostate cancer and found "evidence of DNA damage" in healthy cells after they received chemotherapy. Chemotherapy inhibiting reproduction of cells that divide quickly like those found in tumors.
Researchers focused on a cell known as the fibroblast in the neighborhood of the cancerous tumor. According to CBS News, when the fibroblast was given chemotherapy, the researchers found that it produced a high level of a molecule called WNT16B that enable the growth of cancerous cells.
"The increase in WNT16B was completely unexpected, according to study researcher Peter Nelson of Seattle. Nelson told AFP, "WNT16B, when secreted, would interact with nearby tumor cells and cause them to grow, invade, and resist subsequent therapy."
Tumors often respond well to chemotherapy treatments at first, then experience rapid regrowth and resistance later.
Nelson said it might be possible to use smaller and less toxic doses of chemotherapy during treatments. And according to Gizmodo, the scientists already expect to study the effects of WNT16B suppressants being given along with chemotherapy drugs in preventing the cell growth.
Your normal rehydration process based on glucose mediated sodium absorption is compromised during radiotherapy and chemotherapy. If a glucose containing drink is used for rehydration during radiotherapy or chemotherapy, there will very little absorption of sodium and other electrolytes. This will leave you dehydrated. In addition, because the glucose from the drink is not absorbed, it stays in your intestine and causes osmotic diarrhea. This will exacerbate the vomiting, diarrhea and dehydration that you may already be experiencing as the side effect of radiotherapy or chemotherapy.
Our scientists discovered alternate pathways for rehydration that kick in when the normal glucose mediated sodium absorption starts failing. These alternate pathways are driven by specific amino acids. Enterade – R is a mixture of these specific amino acids in the required concentrations along with electrolytes to rehydrate you when your glucose mediated rehydration process is failing due to radiotherapy or chemotherapy.
The recommended dose of Enterade – R is 2 bottles (8 fl oz each) a day during the course of radiotherapy or chemotherapy. Please ask your healthcare professional if you are planning to use this product.
Please visit www.enterade.com or call 1-855-ENTERADE for more information.
The above statements about Enterade – R have not been evaluated by the FDA. Enterade – R is not intended to diagnose, treat, cure or prevent any disease.
The real solution to cancer is to skip the chemo and focus on the mitochondrial activiation, which can be achieved by various non-pharmaceutical means, including cannabinoids, alkalinity of the body's pH, DCA, topical aqueous bicarbonate, and massive vitamin C doses.
Lots of cancer cures out there, but because they are natural and not patentable, and therefore no money in it, the phamraceutical companies won't pursue them.